BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Short Report
Year : 2026  |  Volume : 17  |  Issue : 4  |  Page : 8886-8890 Full Version
Navigating the diagnostic enigma of rare inherited disorders
Int J Biol Med Res. 2026; 17(4): 8886-8890  |  DOI: 10.65048/ijbmr.2026.17.4.8886.1107
Chemukula Mallikarjuna¹, Vinodhini M¹, Priyadharshini M², Konda Deepthi³
¹ Department of Medical Oncology/ Haematology, All India Institute of Medical Sciences (AIIMS), Bibinagar, Hyderabad Metropolitan Region,
Telangana- 508126.
² Department of Obstetrics and Gynecology, Vadamalayan Hospitals, Dindigul, Tamil Nadu.
³ Department of Dermatology, All India Institute of Medical Sciences (AIIMS), Bibinagar, Hyderabad Metropolitan Region, Telangana- 508126.
Correspondence Address :
Dr.Vinodhini M, MD, DM,
Department of Medical Oncology/ Haematology,
All India Institute of Medical Sciences (AIIMS), Bibinagar,
Hyderabad Metropolitan Region, Telangana- 508126 E-mail: drvino97@yahoo.in
Received: June 2, 2026 Accepted: August 29, 2026 Published: October 3, 2026

Abstract
Inherited disorders of coagulation pathway often pose diagnostic challenges due to heterogenous clinical manifestation particularly when presenting at advanced age. They often go undiagnosed during childhood due to their atypical features, inadequate access to health care, lack of access to comprehensive laboratory workup, molecular testing and limited therapeutic options. In few women, features such as recurrent pregnancy loss, ectopic pregnancy, menorrhagia or infertility may be sole presentation in such rare conditions. Next-generation sequencing has enhanced the ability to accurately diagnose inherited bleeding and immune mediated disorders, enabling better genetic counselling and antenatal screening. We present a series of five cases with varied clinical profile, unexplained bleeding and adverse obstetric outcomes which caused diagnostic and management difficulties due to limited data in literature. This emphasizes the need to consider early application of molecular testing in such cases to improve diagnostic accuracy, guide appropriate management.
Keywords
Factor XIII deficiency, CD36 deficiency, OTULIN, Auto-inflammation, Angioedema, Vitamin K deficiency

References

[1] Thomas W, Downes K, Desborough MJR. Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management. Haemophilia. 2020;26(6):946-957. doi:10.1111/hae.14174
[2] Baker RI, Choi P, Curry N, et al. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH. J Thromb Haemost. 2024;22(7):2059-2070. doi:10.1016/j.jtha.2024.03.005
[3] Mehic D, Pabinger I, Gebhart J. Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out. Res Pract Thromb Haemost. 2023;7(8):102242. Published 2023 Oct 30. doi:10.1016/j.rpth.2023.102242.
[4] Ito Y, Tsuji S, Kasahara M, Tokoro S, Murakami T, Takayama H. Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII: A case report and literature review. J Obstet Gynaecol Res. 2024;50(2):262-265. doi:10.1111/jog.15819.
[5] Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood. 2019;133(5):415-424. doi:10.1182/blood-2018-06-820738.
[6] Abdel-Samad N. Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency. Am J Case Rep. 2017;18:436-439. Published 2017 Apr 22. doi:10.12659/ajcr.901502.
[7] Xia W, Chen D, Li X, et al. Haplotypes analysis reveals the genetic basis of type I CD36 deficiency. Sci Rep. 2024;14(1):23977. Published 2024 Oct 14. doi:10.1038/s41598-024-74917-0.
[8] Yang YD, Dai WS, Zhang YL, Li DZ. Recurrent Fetal Hydrops with Severe Anemia and Thrombocytopenia Caused by Maternal CD36 Deficiency. Indian J Hematol Blood Transfus. 2026;42(3):1088-1090. doi:10.1007/s12288-025-02091-y.
[9] Setchell KD, Heubi JE, Shah S, et al. Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology. 2013;144(5):945-e15. doi:10.1053/j.gastro.2013.02.004.
[10] Caballero-Oteyza A, Crisponi L, Peng XP, et al. OTULIN-related conditions: Report of a new case and review of the literature using GenIA. Preprint. Res Sq. 2024;rs.3.rs-3950863. Published 2024 Mar 8. doi:10.21203/rs.3.rs-3950863/v2.
[11] Dou B, Jiang G, Peng W, Liu C. OTULIN deficiency: focus on innate immune system impairment. Front Immunol. 2024;15:1371564. Published 2024 May 7. doi:10.3389/fimmu.2024.1371564.
[12] Fijen LM, Riedl MA, Bordone L, et al. Inhibition of Prekallikrein for Hereditary Angioedema. N Engl J Med. 2022;386(11):1026-1033. doi:10.1056/NEJMoa2109329.
[13] Ji R, Xu Y, Zhi Y. Elevated level of circulating VEGF in Chinese patients with hereditary angioedema and its correlation with disease status. Orphanet J Rare Dis. 2025;20(1):251. Published 2025 May 26. doi:10.1186/s13023-025-03776-3.


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications